Vivo Capital’s KalVista Pharmaceuticals KALV Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-856,008	Closed	-$10.5M	–	46
2023 Q4	$10.5M	Hold	856,008	–	–	0.86%	24
2023 Q3	$8.24M	Hold	856,008	–	–	0.9%	28
2023 Q2	$7.7M	Hold	856,008	–	–	0.53%	27
2023 Q1	$6.73M	Hold	856,008	–	–	0.47%	27
2022 Q4	$5.79M	Sell	856,008 -677,551	-44%	-$4.58M	0.67%	30
2022 Q3	$22.3M	Hold	1,533,559	–	–	2.46%	15
2022 Q2	$15.1M	Hold	1,533,559	–	–	1.52%	14
2022 Q1	$22.6M	Hold	1,533,559	–	–	1.56%	13
2021 Q4	$20.3M	Sell	1,533,559 -108,354	-7%	-$1.43M	1.22%	18
2021 Q3	$28.7M	Sell	1,641,913 -221,383	-12%	-$3.86M	1.29%	19
2021 Q2	$44.6M	Hold	1,863,296	–	–	1.93%	11
2021 Q1	$47.9M	Buy	1,863,296 +245,000	+15%	+$6.29M	1.68%	14
2020 Q4	$30.7M	Buy	1,618,296 +141,500	+10%	+$2.69M	1.37%	16
2020 Q3	$18.6M	Hold	1,476,796	–	–	1.07%	24
2020 Q2	$17.9M	Hold	1,476,796	–	–	1.28%	20
2020 Q1	$11.3M	Buy	+1,476,796	New	+$11.3M	1.02%	30
2019 Q3	–	Sell	-1,359,149	Closed	-$30.1M	–	20
2019 Q2	$30.1M	Hold	1,359,149	–	–	2.82%	10
2019 Q1	$38.9M	Hold	1,359,149	–	–	3.88%	5
2018 Q4	$26.8M	Hold	1,359,149	–	–	3.43%	7
2018 Q3	$30.1M	Buy	1,359,149 +1,058,824	+353%	+$23.4M	3.03%	11
2018 Q2	$2.44M	Hold	300,325	–	–	0.31%	36
2018 Q1	$2.85M	Hold	300,325	–	–	0.4%	30
2017 Q4	$2.93M	Hold	300,325	–	–	0.63%	24
2017 Q3	$2.02M	Buy	+300,325	New	+$2.02M	0.41%	27
2017 Q2	–	Sell	-300,325	Closed	-$2.35M	–	27
2017 Q1	$2.35M	Hold	300,325	–	–	0.69%	19
2016 Q4	$2.12M	Sell	300,325 -3,904,237	-93%	-$27.6M	0.7%	19
2016 Q3	$1.93M	Hold	4,204,562	–	–	0.6%	17
2016 Q2	$2.78M	Hold	4,204,562	–	–	0.76%	16
2016 Q1	$2.69M	Buy	+4,204,562	New	+$2.69M	0.68%	18